fanta.bio Sample: CNhs11931
12491 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 701 / 6452 (10.9%) | 237 / 64520 (0.4%) | −324.0 | −324.0 | 29.58 |
| HIF1A SRX11007095 | HK-2 Kidney | 1262 / 6452 (19.6%) | 462 / 64520 (0.7%) | −324.0 | −324.0 | 27.32 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 989 / 6452 (15.3%) | 372 / 64520 (0.6%) | −324.0 | −324.0 | 26.59 |
| SCML2 SRX644728 | 293 Kidney | 866 / 6452 (13.4%) | 360 / 64520 (0.6%) | −324.0 | −324.0 | 24.06 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 954 / 6452 (14.8%) | 410 / 64520 (0.6%) | −324.0 | −324.0 | 23.27 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1313 / 6452 (20.4%) | 587 / 64520 (0.9%) | −324.0 | −324.0 | 22.37 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1283 / 6452 (19.9%) | 584 / 64520 (0.9%) | −324.0 | −324.0 | 21.97 |
| FOXP1 SRX736067 | LNCAP Prostate | 660 / 6452 (10.2%) | 587 / 64520 (0.9%) | −324.0 | −324.0 | 11.24 |
| BRD4 SRX9419935 | BT-474 Breast | 1296 / 6452 (20.1%) | 1407 / 64520 (2.2%) | −324.0 | −324.0 | 9.21 |
| BRD4 SRX9419937 | BT-474 Breast | 1326 / 6452 (20.6%) | 1463 / 64520 (2.3%) | −324.0 | −324.0 | 9.06 |
| MED1 SRX9419945 | BT-474 Breast | 1273 / 6452 (19.7%) | 1425 / 64520 (2.2%) | −324.0 | −324.0 | 8.93 |
| BRD4 SRX9419936 | BT-474 Breast | 1330 / 6452 (20.6%) | 1489 / 64520 (2.3%) | −324.0 | −324.0 | 8.93 |
| MED1 SRX9419944 | BT-474 Breast | 1254 / 6452 (19.4%) | 1427 / 64520 (2.2%) | −324.0 | −324.0 | 8.79 |
| MED1 SRX9419947 | BT-474 Breast | 1274 / 6452 (19.7%) | 1450 / 64520 (2.2%) | −324.0 | −324.0 | 8.79 |
| MED1 SRX9419946 | BT-474 Breast | 1311 / 6452 (20.3%) | 1503 / 64520 (2.3%) | −324.0 | −324.0 | 8.72 |
| BRD4 SRX736201 | 90-8TL Neural | 2561 / 6452 (39.7%) | 2969 / 64520 (4.6%) | −324.0 | −324.0 | 8.63 |
| BRD4 SRX9419938 | BT-474 Breast | 1278 / 6452 (19.8%) | 1489 / 64520 (2.3%) | −324.0 | −324.0 | 8.58 |
| EZH2 SRX2146136 | LNCAP Prostate | 3076 / 6452 (47.7%) | 3779 / 64520 (5.9%) | −324.0 | −324.0 | 8.14 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 884 / 6452 (13.7%) | 1155 / 64520 (1.8%) | −324.0 | −324.0 | 7.65 |
| TP53 SRX19538279 | Osteoblasts Bone | 402 / 6452 (6.2%) | 124 / 64520 (0.2%) | −305.1 | −301.9 | 32.42 |
| TP53 SRX19538274 | U2OS Bone | 333 / 6452 (5.2%) | 71 / 64520 (0.1%) | −272.7 | −269.5 | 46.90 |
| TP53 SRX19538268 | U2OS Bone | 329 / 6452 (5.1%) | 67 / 64520 (0.1%) | −271.7 | −268.5 | 49.10 |
| TP53 SRX19538276 | U2OS Bone | 335 / 6452 (5.2%) | 79 / 64520 (0.1%) | −269.1 | −266.0 | 42.41 |
| TP53 SRX19538267 | U2OS Bone | 300 / 6452 (4.6%) | 67 / 64520 (0.1%) | −243.4 | −240.2 | 44.78 |
| TP53 SRX19538275 | U2OS Bone | 302 / 6452 (4.7%) | 75 / 64520 (0.1%) | −239.9 | −236.8 | 40.27 |
| TP53 SRX19538273 | U2OS Bone | 294 / 6452 (4.6%) | 66 / 64520 (0.1%) | −238.2 | −235.1 | 44.55 |
| TP53 SRX19538280 | Osteoblasts Bone | 316 / 6452 (4.9%) | 100 / 64520 (0.2%) | −237.8 | −234.7 | 31.60 |
| TP53 SRX19538281 | Osteoblasts Bone | 335 / 6452 (5.2%) | 139 / 64520 (0.2%) | −234.7 | −231.6 | 24.10 |
| TP53 SRX19538269 | U2OS Bone | 352 / 6452 (5.5%) | 179 / 64520 (0.3%) | −231.5 | −228.4 | 19.66 |
| TP53 SRX19538270 | U2OS Bone | 336 / 6452 (5.2%) | 172 / 64520 (0.3%) | −220.4 | −217.3 | 19.53 |
| TP53 SRX19538271 | U2OS Bone | 453 / 6452 (7.0%) | 484 / 64520 (0.8%) | −216.6 | −213.6 | 9.36 |
| MYH11 SRX265221 | ME-1 Blood | 382 / 6452 (5.9%) | 309 / 64520 (0.5%) | −209.6 | −206.6 | 12.36 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 694 / 6452 (10.8%) | 1448 / 64520 (2.2%) | −208.1 | −205.1 | 4.79 |
| IRF3 SRX11453858 | Hep G2 Liver | 232 / 6452 (3.6%) | 39 / 64520 (0.1%) | −197.5 | −194.5 | 59.49 |
| TP53 SRX19538282 | Osteoblasts Bone | 286 / 6452 (4.4%) | 138 / 64520 (0.2%) | −191.0 | −188.1 | 20.72 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 378 / 6452 (5.9%) | 369 / 64520 (0.6%) | −189.2 | −186.2 | 10.24 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 260 / 6452 (4.0%) | 108 / 64520 (0.2%) | −181.7 | −178.8 | 24.07 |
| HIF1A SRX20663235 | HK-2 Kidney | 257 / 6452 (4.0%) | 123 / 64520 (0.2%) | −172.0 | −169.1 | 20.89 |
| BRD4 SRX736204 | 90-8TL Neural | 568 / 6452 (8.8%) | 1169 / 64520 (1.8%) | −171.2 | −168.3 | 4.86 |
| IRF3 SRX11453861 | Hep G2 Liver | 203 / 6452 (3.1%) | 40 / 64520 (0.1%) | −168.2 | −165.3 | 50.75 |
| TP53 SRX19538272 | U2OS Bone | 374 / 6452 (5.8%) | 446 / 64520 (0.7%) | −167.4 | −164.5 | 8.39 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 330 / 6452 (5.1%) | 377 / 64520 (0.6%) | −151.3 | −148.4 | 8.75 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 469 / 6452 (7.3%) | 937 / 64520 (1.5%) | −144.4 | −141.6 | 5.01 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 612 / 6452 (9.5%) | 1611 / 64520 (2.5%) | −144.0 | −141.2 | 3.80 |
| KAT6A SRX20971022 | Fibroblasts Others | 175 / 6452 (2.7%) | 45 / 64520 (0.1%) | −137.8 | −134.9 | 38.89 |
| AGO2 SRX4708039 | Hep G2 Liver | 831 / 6452 (12.9%) | 2947 / 64520 (4.6%) | −134.1 | −131.2 | 2.82 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 175 / 6452 (2.7%) | 61 / 64520 (0.1%) | −128.3 | −125.4 | 28.69 |
| AR SRX10820653 | LNCAP Prostate | 199 / 6452 (3.1%) | 109 / 64520 (0.2%) | −127.2 | −124.4 | 18.26 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 324 / 6452 (5.0%) | 593 / 64520 (0.9%) | −107.0 | −104.1 | 5.46 |
| AR SRX10820651 | LNCAP Prostate | 194 / 6452 (3.0%) | 158 / 64520 (0.2%) | −105.7 | −102.9 | 12.28 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 306 / 6452 (4.7%) | 553 / 64520 (0.9%) | −102.0 | −99.2 | 5.53 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 275 / 6452 (4.3%) | 458 / 64520 (0.7%) | −97.8 | −95.0 | 6.00 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 583 / 6452 (9.0%) | 2026 / 64520 (3.1%) | −95.2 | −92.5 | 2.88 |
| BMI1 SRX644729 | 293 Kidney | 141 / 6452 (2.2%) | 74 / 64520 (0.1%) | −91.6 | −88.8 | 19.05 |
| AGO2 SRX6783958 | Hep G2 Liver | 510 / 6452 (7.9%) | 1704 / 64520 (2.6%) | −87.9 | −85.1 | 2.99 |
| Epitope tags SRX10549776 | K-562 Blood | 563 / 6452 (8.7%) | 2055 / 64520 (3.2%) | −85.1 | −82.3 | 2.74 |
| AGO2 SRX6783957 | Hep G2 Liver | 511 / 6452 (7.9%) | 1760 / 64520 (2.7%) | −84.2 | −81.5 | 2.90 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 124 / 6452 (1.9%) | 65 / 64520 (0.1%) | −80.6 | −77.9 | 19.08 |
| LEO1 SRX1873456 | SEM Blood | 590 / 6452 (9.1%) | 2314 / 64520 (3.6%) | −79.2 | −76.4 | 2.55 |
| RUNX1 SRX2513054 | 293 Kidney | 1237 / 6452 (19.2%) | 6940 / 64520 (10.8%) | −78.4 | −75.6 | 1.78 |
| CDK9 SRX7366781 | MCF-7 Breast | 116 / 6452 (1.8%) | 56 / 64520 (0.1%) | −77.5 | −74.8 | 20.71 |
| CDK9 SRX7366783 | MCF-7 Breast | 119 / 6452 (1.8%) | 63 / 64520 (0.1%) | −77.1 | −74.4 | 18.89 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 796 / 6452 (12.3%) | 3782 / 64520 (5.9%) | −74.2 | −71.5 | 2.10 |
| KAT7 SRX101303 | RKO Digestive tract | 529 / 6452 (8.2%) | 2028 / 64520 (3.1%) | −73.6 | −70.9 | 2.61 |
| STAT5B SRX831881 | CD8+ T cells Blood | 122 / 6452 (1.9%) | 79 / 64520 (0.1%) | −73.4 | −70.7 | 15.44 |
| NFYB SRX16608147 | HeLa Uterus | 127 / 6452 (2.0%) | 96 / 64520 (0.1%) | −71.7 | −69.0 | 13.23 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 225 / 6452 (3.5%) | 430 / 64520 (0.7%) | −71.5 | −68.8 | 5.23 |
| LARP7 SRX2198835 | HeLa Uterus | 841 / 6452 (13.0%) | 4170 / 64520 (6.5%) | −71.2 | −68.6 | 2.02 |
| FOXA1 SRX4815198 | MCF-7 Breast | 451 / 6452 (7.0%) | 9319 / 64520 (14.4%) | −70.8 | −68.2 | 0.48 |
| BRPF3 SRX796085 | RKO Digestive tract | 426 / 6452 (6.6%) | 1469 / 64520 (2.3%) | −69.7 | −67.0 | 2.90 |
| BRPF3 SRX796084 | RKO Digestive tract | 581 / 6452 (9.0%) | 2425 / 64520 (3.8%) | −69.6 | −66.9 | 2.40 |
| BRD1 SRX286203 | RKO Digestive tract | 452 / 6452 (7.0%) | 1630 / 64520 (2.5%) | −69.0 | −66.4 | 2.77 |
| ETS1 SRX3033231 | HEYA8 Gonad | 142 / 6452 (2.2%) | 148 / 64520 (0.2%) | −68.5 | −65.9 | 9.59 |
| FOXA1 SRX4815197 | MCF-7 Breast | 341 / 6452 (5.3%) | 7648 / 64520 (11.9%) | −66.9 | −64.2 | 0.45 |
| PBX4 SRX2731658 | PC-3 Prostate | 512 / 6452 (7.9%) | 9945 / 64520 (15.4%) | −66.6 | −63.9 | 0.51 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 524 / 6452 (8.1%) | 2149 / 64520 (3.3%) | −64.7 | −62.1 | 2.44 |
| ESR1 SRX4367193 | MCF-7 Breast | 442 / 6452 (6.9%) | 8909 / 64520 (13.8%) | −64.0 | −61.4 | 0.50 |
| FOXA1 SRX3931044 | MCF-7 Breast | 308 / 6452 (4.8%) | 7066 / 64520 (11.0%) | −64.0 | −61.4 | 0.44 |
| ING5 SRX286202 | RKO Digestive tract | 503 / 6452 (7.8%) | 2028 / 64520 (3.1%) | −64.0 | −61.3 | 2.48 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 102 / 6452 (1.6%) | 3863 / 64520 (6.0%) | −63.8 | −61.2 | 0.26 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 94 / 6452 (1.5%) | 45 / 64520 (0.1%) | −63.1 | −60.5 | 20.89 |
| CIC SRX13262055 | Astrocytes Neural | 1125 / 6452 (17.4%) | 6538 / 64520 (10.1%) | −63.1 | −60.5 | 1.72 |
| ESR1 SRX7624157 | MCF-7 Breast | 368 / 6452 (5.7%) | 7862 / 64520 (12.2%) | −62.8 | −60.2 | 0.47 |
| 5-mC SRX882970 | LNCAP Prostate | 1045 / 6452 (16.2%) | 5924 / 64520 (9.2%) | −62.8 | −60.2 | 1.76 |
| BRPF3 SRX796086 | RKO Digestive tract | 542 / 6452 (8.4%) | 2300 / 64520 (3.6%) | −62.8 | −60.2 | 2.36 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 202 / 6452 (3.1%) | 397 / 64520 (0.6%) | −62.7 | −60.1 | 5.09 |
| SSRP1 SRX3436567 | HT-1080 Bone | 165 / 6452 (2.6%) | 254 / 64520 (0.4%) | −62.3 | −59.7 | 6.50 |
| Epitope tags SRX20570808 | Keratinocytes Epidermis | 360 / 6452 (5.6%) | 1193 / 64520 (1.8%) | −62.2 | −59.7 | 3.02 |
| FOXA1 SRX176863 | MCF-7 Breast | 178 / 6452 (2.8%) | 5046 / 64520 (7.8%) | −61.5 | −58.9 | 0.35 |
| MECOM SRX23677897 | HNT-34 Blood | 777 / 6452 (12.0%) | 3954 / 64520 (6.1%) | −61.3 | −58.8 | 1.97 |
| MECOM SRX23677885 | HNT-34 Blood | 659 / 6452 (10.2%) | 3125 / 64520 (4.8%) | −60.9 | −58.4 | 2.11 |
| FOXA1 SRX176862 | MCF-7 Breast | 196 / 6452 (3.0%) | 5303 / 64520 (8.2%) | −60.9 | −58.4 | 0.37 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 197 / 6452 (3.1%) | 394 / 64520 (0.6%) | −60.2 | −57.7 | 5.00 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 618 / 6452 (9.6%) | 2862 / 64520 (4.4%) | −60.1 | −57.6 | 2.16 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 721 / 6452 (11.2%) | 3586 / 64520 (5.6%) | −60.0 | −57.5 | 2.01 |
| CBX3 SRX055348 | HCT 116 Digestive tract | 155 / 6452 (2.4%) | 231 / 64520 (0.4%) | −59.9 | −57.4 | 6.71 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 94 / 6452 (1.5%) | 53 / 64520 (0.1%) | −59.7 | −57.2 | 17.74 |
| MECOM SRX23677884 | HNT-34 Blood | 650 / 6452 (10.1%) | 3093 / 64520 (4.8%) | −59.6 | −57.1 | 2.10 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 178 / 6452 (2.8%) | 4966 / 64520 (7.7%) | −59.3 | −56.8 | 0.36 |
| ESR1 SRX371469 | MCF-7 Breast | 157 / 6452 (2.4%) | 4633 / 64520 (7.2%) | −59.2 | −56.7 | 0.34 |
| ESR1 SRX7624156 | MCF-7 Breast | 237 / 6452 (3.7%) | 5856 / 64520 (9.1%) | −59.2 | −56.7 | 0.40 |
| 5-mC SRX882965 | LNCAP Prostate | 862 / 6452 (13.4%) | 4640 / 64520 (7.2%) | −59.1 | −56.6 | 1.86 |
| FOXA1 SRX1161177 | MCF-7 Breast | 154 / 6452 (2.4%) | 4578 / 64520 (7.1%) | −59.0 | −56.5 | 0.34 |
| SSRP1 SRX3436566 | HT-1080 Bone | 136 / 6452 (2.1%) | 172 / 64520 (0.3%) | −58.7 | −56.2 | 7.91 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 252 / 6452 (3.9%) | 666 / 64520 (1.0%) | −58.2 | −55.7 | 3.78 |
| ESR1 SRX20282961 | MCF-7 Breast | 191 / 6452 (3.0%) | 5125 / 64520 (7.9%) | −58.1 | −55.6 | 0.37 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 293 / 6452 (4.5%) | 879 / 64520 (1.4%) | −58.0 | −55.5 | 3.33 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 719 / 6452 (11.1%) | 3620 / 64520 (5.6%) | −58.0 | −55.5 | 1.99 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 331 / 6452 (5.1%) | 7151 / 64520 (11.1%) | −58.0 | −55.5 | 0.46 |
| 5-mC SRX882968 | LNCAP Prostate | 1020 / 6452 (15.8%) | 5883 / 64520 (9.1%) | −58.0 | −55.5 | 1.73 |
| ESR1 SRX371478 | MCF-7 Breast | 196 / 6452 (3.0%) | 5189 / 64520 (8.0%) | −57.7 | −55.3 | 0.38 |
| ESR1 SRX4451199 | MCF-7 Breast | 209 / 6452 (3.2%) | 466 / 64520 (0.7%) | −57.7 | −55.3 | 4.48 |
| SREBF2 SRX5359048 | HCC70 Breast | 629 / 6452 (9.7%) | 2995 / 64520 (4.6%) | −57.5 | −55.1 | 2.10 |
| ESR1 SRX371479 | MCF-7 Breast | 141 / 6452 (2.2%) | 4313 / 64520 (6.7%) | −57.5 | −55.0 | 0.33 |
| GRHL3 SRX2582162 | NHEK Epidermis | 399 / 6452 (6.2%) | 1501 / 64520 (2.3%) | −56.9 | −54.4 | 2.66 |
| ESR1 SRX20282960 | MCF-7 Breast | 174 / 6452 (2.7%) | 4815 / 64520 (7.5%) | −56.8 | −54.3 | 0.36 |
| ESR1 SRX194572 | MCF-7 Breast | 94 / 6452 (1.5%) | 3497 / 64520 (5.4%) | −56.7 | −54.3 | 0.27 |
| ESR1 SRX4451197 | MCF-7 Breast | 289 / 6452 (4.5%) | 876 / 64520 (1.4%) | −56.5 | −54.0 | 3.30 |
| GATA3 SRX190239 | MCF-7 Breast | 230 / 6452 (3.6%) | 5647 / 64520 (8.8%) | −56.4 | −53.9 | 0.41 |
| IRF3 SRX11453864 | Hep G2 Liver | 73 / 6452 (1.1%) | 21 / 64520 (0.0%) | −56.4 | −53.9 | 34.76 |
| CDK9 SRX7366779 | MCF-7 Breast | 86 / 6452 (1.3%) | 45 / 64520 (0.1%) | −56.1 | −53.7 | 19.11 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 663 / 6452 (10.3%) | 3268 / 64520 (5.1%) | −56.1 | −53.7 | 2.03 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 635 / 6452 (9.8%) | 3074 / 64520 (4.8%) | −56.0 | −53.6 | 2.07 |
| PTEN SRX5416007 | SMMC-7721 Liver | 666 / 6452 (10.3%) | 3296 / 64520 (5.1%) | −55.9 | −53.5 | 2.02 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 628 / 6452 (9.7%) | 3036 / 64520 (4.7%) | −55.4 | −53.0 | 2.07 |
| FOXA1 SRX371481 | MCF-7 Breast | 168 / 6452 (2.6%) | 4670 / 64520 (7.2%) | −55.3 | −52.9 | 0.36 |
| Epitope tags SRX15426925 | Keratinocytes Epidermis | 234 / 6452 (3.6%) | 606 / 64520 (0.9%) | −55.3 | −52.9 | 3.86 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 273 / 6452 (4.2%) | 806 / 64520 (1.2%) | −55.2 | −52.8 | 3.39 |
| FOXA1 SRX1161173 | MCF-7 Breast | 123 / 6452 (1.9%) | 3939 / 64520 (6.1%) | −55.1 | −52.7 | 0.31 |
| MECOM SRX23677896 | HNT-34 Blood | 784 / 6452 (12.2%) | 4173 / 64520 (6.5%) | −55.1 | −52.7 | 1.88 |
| TLE3 SRX4815191 | MCF-7 Breast | 153 / 6452 (2.4%) | 4418 / 64520 (6.8%) | −54.9 | −52.5 | 0.35 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 666 / 6452 (10.3%) | 3321 / 64520 (5.1%) | −54.8 | −52.4 | 2.01 |
| ESR1 SRX176861 | MCF-7 Breast | 254 / 6452 (3.9%) | 5933 / 64520 (9.2%) | −54.7 | −52.3 | 0.43 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 305 / 6452 (4.7%) | 986 / 64520 (1.5%) | −54.7 | −52.3 | 3.09 |
| ESR1 SRX371471 | ZR-75-1 Breast | 174 / 6452 (2.7%) | 4735 / 64520 (7.3%) | −54.5 | −52.2 | 0.37 |
| FOXA1 SRX371482 | MCF-7 Breast | 232 / 6452 (3.6%) | 5596 / 64520 (8.7%) | −54.3 | −51.9 | 0.41 |
| ESR1 SRX371468 | MCF-7 Breast | 100 / 6452 (1.5%) | 3526 / 64520 (5.5%) | −54.3 | −51.9 | 0.28 |
| ESR1 SRX1531791 | MCF-7 Breast | 153 / 6452 (2.4%) | 4388 / 64520 (6.8%) | −54.0 | −51.6 | 0.35 |
| ESR1 SRX176860 | MCF-7 Breast | 252 / 6452 (3.9%) | 5875 / 64520 (9.1%) | −53.9 | −51.6 | 0.43 |
| ESR1 SRX194569 | MCF-7 Breast | 165 / 6452 (2.6%) | 4549 / 64520 (7.1%) | −53.3 | −50.9 | 0.36 |
| ESR1 SRX371470 | ZR-75-1 Breast | 148 / 6452 (2.3%) | 4281 / 64520 (6.6%) | −53.2 | −50.8 | 0.35 |
| CDYL2 SRX8321653 | MCF-7 Breast | 663 / 6452 (10.3%) | 3339 / 64520 (5.2%) | −53.2 | −50.8 | 1.99 |
| GATA3 SRX176864 | MCF-7 Breast | 120 / 6452 (1.9%) | 3825 / 64520 (5.9%) | −53.1 | −50.7 | 0.31 |
| Epitope tags SRX10549778 | K-562 Blood | 412 / 6452 (6.4%) | 1646 / 64520 (2.6%) | −53.0 | −50.6 | 2.50 |
| ESR1 SRX371467 | MCF-7 Breast | 166 / 6452 (2.6%) | 4546 / 64520 (7.0%) | −52.8 | −50.4 | 0.37 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 405 / 6452 (6.3%) | 1607 / 64520 (2.5%) | −52.7 | −50.4 | 2.52 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 268 / 6452 (4.2%) | 6044 / 64520 (9.4%) | −52.5 | −50.1 | 0.44 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 158 / 6452 (2.4%) | 288 / 64520 (0.4%) | −52.4 | −50.0 | 5.49 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 707 / 6452 (11.0%) | 3682 / 64520 (5.7%) | −52.3 | −50.0 | 1.92 |
| NCOA1 SRX036638 | U2OS Bone | 79 / 6452 (1.2%) | 40 / 64520 (0.1%) | −52.2 | −49.8 | 19.75 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 192 / 6452 (3.0%) | 4923 / 64520 (7.6%) | −52.1 | −49.8 | 0.39 |
| FOXA1 SRX1161175 | MCF-7 Breast | 121 / 6452 (1.9%) | 3802 / 64520 (5.9%) | −52.0 | −49.7 | 0.32 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 321 / 6452 (5.0%) | 1114 / 64520 (1.7%) | −51.9 | −49.5 | 2.88 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 165 / 6452 (2.6%) | 321 / 64520 (0.5%) | −51.8 | −49.4 | 5.14 |
| FOXA1 SRX1787653 | MCF-7 Breast | 132 / 6452 (2.0%) | 3965 / 64520 (6.1%) | −51.6 | −49.2 | 0.33 |
| MITF SRX1555436 | 501A Epidermis | 703 / 6452 (10.9%) | 3681 / 64520 (5.7%) | −51.3 | −48.9 | 1.91 |
| TRP47 SRX4548329 | THP-1 Blood | 937 / 6452 (14.5%) | 5457 / 64520 (8.5%) | −51.2 | −48.9 | 1.72 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 570 / 6452 (8.8%) | 2734 / 64520 (4.2%) | −51.0 | −48.7 | 2.08 |
| KMT2A SRX2323891 | 293 Kidney | 360 / 6452 (5.6%) | 1359 / 64520 (2.1%) | −50.9 | −48.6 | 2.65 |
| BMI1 SRX7196721 | SF8628 Neural | 612 / 6452 (9.5%) | 3047 / 64520 (4.7%) | −50.3 | −48.0 | 2.01 |
| MECOM SRX23677890 | HNT-34 Blood | 652 / 6452 (10.1%) | 3340 / 64520 (5.2%) | −50.1 | −47.8 | 1.95 |
| CDK9 SRX7366784 | MCF-7 Breast | 78 / 6452 (1.2%) | 43 / 64520 (0.1%) | −50.1 | −47.8 | 18.14 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 208 / 6452 (3.2%) | 530 / 64520 (0.8%) | −50.0 | −47.7 | 3.92 |
| FOXA1 SRX1161176 | MCF-7 Breast | 160 / 6452 (2.5%) | 4353 / 64520 (6.7%) | −50.0 | −47.7 | 0.37 |
| FOXA1 SRX028634 | MCF-7 Breast | 81 / 6452 (1.3%) | 3056 / 64520 (4.7%) | −50.0 | −47.7 | 0.27 |
| ERG SRX063921 | K-562 Blood | 541 / 6452 (8.4%) | 2565 / 64520 (4.0%) | −49.7 | −47.4 | 2.11 |
| ESR1 SRX20282954 | MCF-7 Breast | 182 / 6452 (2.8%) | 4678 / 64520 (7.3%) | −49.7 | −47.4 | 0.39 |
| RORC SRX5359052 | HCC70 Breast | 463 / 6452 (7.2%) | 2038 / 64520 (3.2%) | −49.6 | −47.3 | 2.27 |
| Epitope tags SRX15426922 | Keratinocytes Epidermis | 283 / 6452 (4.4%) | 931 / 64520 (1.4%) | −49.5 | −47.2 | 3.04 |
| RBM22 SRX4708083 | K-562 Blood | 343 / 6452 (5.3%) | 1283 / 64520 (2.0%) | −49.3 | −47.0 | 2.67 |
| GFP SRX12567758 | MRC-5 Lung | 544 / 6452 (8.4%) | 2596 / 64520 (4.0%) | −49.2 | −47.0 | 2.10 |
| CBX3 SRX055346 | HCT 116 Digestive tract | 104 / 6452 (1.6%) | 113 / 64520 (0.2%) | −49.2 | −46.9 | 9.20 |
| ESR1 SRX20282939 | MCF-7 Breast | 194 / 6452 (3.0%) | 4835 / 64520 (7.5%) | −49.1 | −46.8 | 0.40 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 126 / 6452 (2.0%) | 3783 / 64520 (5.9%) | −49.0 | −46.8 | 0.33 |
| FOS SRX150477 | MCF 10A Breast | 382 / 6452 (5.9%) | 7457 / 64520 (11.6%) | −49.0 | −46.7 | 0.51 |
| GATA3 SRX5057632 | MCF-7 Breast | 113 / 6452 (1.8%) | 3560 / 64520 (5.5%) | −48.7 | −46.4 | 0.32 |
| ERG SRX063922 | K-562 Blood | 565 / 6452 (8.8%) | 2759 / 64520 (4.3%) | −48.6 | −46.3 | 2.05 |
| NABP2 SRX9523535 | HT-1080 Bone | 495 / 6452 (7.7%) | 2275 / 64520 (3.5%) | −48.5 | −46.2 | 2.18 |
| FOXA1 SRX371483 | MCF-7 Breast | 194 / 6452 (3.0%) | 4814 / 64520 (7.5%) | −48.5 | −46.2 | 0.40 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 594 / 6452 (9.2%) | 2967 / 64520 (4.6%) | −48.4 | −46.1 | 2.00 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 362 / 6452 (5.6%) | 7164 / 64520 (11.1%) | −48.4 | −46.1 | 0.51 |
| ESR1 SRX20282972 | MCF-7 Breast | 190 / 6452 (2.9%) | 4741 / 64520 (7.3%) | −48.2 | −45.9 | 0.40 |
| MECOM SRX23677891 | HNT-34 Blood | 639 / 6452 (9.9%) | 3300 / 64520 (5.1%) | −48.1 | −45.8 | 1.94 |
| ESR1 SRX10365536 | MCF-7 Breast | 92 / 6452 (1.4%) | 3185 / 64520 (4.9%) | −48.0 | −45.8 | 0.29 |
| ESR1 SRX371476 | MCF-7 Breast | 127 / 6452 (2.0%) | 3763 / 64520 (5.8%) | −47.9 | −45.7 | 0.34 |
| FOXA1 SRX3923517 | MCF-7 Breast | 121 / 6452 (1.9%) | 3662 / 64520 (5.7%) | −47.9 | −45.6 | 0.33 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 671 / 6452 (10.4%) | 3539 / 64520 (5.5%) | −47.8 | −45.6 | 1.90 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 161 / 6452 (2.5%) | 4288 / 64520 (6.6%) | −47.8 | −45.6 | 0.38 |
| ESR1 SRX4367192 | MCF-7 Breast | 327 / 6452 (5.1%) | 6664 / 64520 (10.3%) | −47.7 | −45.5 | 0.49 |
| GFP SRX12567763 | MRC-5 Lung | 599 / 6452 (9.3%) | 3023 / 64520 (4.7%) | −47.6 | −45.3 | 1.98 |
| RBFOX2 SRX4708082 | K-562 Blood | 848 / 6452 (13.1%) | 4888 / 64520 (7.6%) | −47.5 | −45.2 | 1.73 |
| CDK9 SRX20230574 | Ishikawa Uterus | 539 / 6452 (8.4%) | 2605 / 64520 (4.0%) | −47.4 | −45.2 | 2.07 |
| ESR1 SRX2881000 | MCF-7 Breast | 150 / 6452 (2.3%) | 4105 / 64520 (6.4%) | −47.3 | −45.1 | 0.37 |
| TP53 SRX396254 | Fibroblasts Others | 305 / 6452 (4.7%) | 1088 / 64520 (1.7%) | −47.3 | −45.0 | 2.80 |
| ESR1 SRX10365535 | MCF-7 Breast | 137 / 6452 (2.1%) | 3896 / 64520 (6.0%) | −47.2 | −45.0 | 0.35 |
| NR2F2 SRX190293 | MCF-7 Breast | 177 / 6452 (2.7%) | 4512 / 64520 (7.0%) | −47.2 | −45.0 | 0.39 |
| CDK9 SRX7366780 | MCF-7 Breast | 76 / 6452 (1.2%) | 46 / 64520 (0.1%) | −47.2 | −45.0 | 16.52 |
| ESR1 SRX371477 | MCF-7 Breast | 86 / 6452 (1.3%) | 3050 / 64520 (4.7%) | −47.1 | −44.9 | 0.28 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 117 / 6452 (1.8%) | 3572 / 64520 (5.5%) | −47.1 | −44.9 | 0.33 |
| FOXA1 SRX1787655 | MCF-7 Breast | 86 / 6452 (1.3%) | 3024 / 64520 (4.7%) | −46.3 | −44.1 | 0.28 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 74 / 6452 (1.1%) | 44 / 64520 (0.1%) | −46.3 | −44.1 | 16.82 |
| GRHL3 SRX2582161 | NHEK Epidermis | 321 / 6452 (5.0%) | 1198 / 64520 (1.9%) | −46.3 | −44.1 | 2.68 |
| ESR1 SRX2943591 | MCF-7 Breast | 121 / 6452 (1.9%) | 3606 / 64520 (5.6%) | −46.3 | −44.1 | 0.34 |
| TLE3 SRX4815192 | MCF-7 Breast | 155 / 6452 (2.4%) | 4140 / 64520 (6.4%) | −46.2 | −44.0 | 0.37 |
| Epitope tags SRX14024875 | Mesenchymal stem cells Others | 644 / 6452 (10.0%) | 3389 / 64520 (5.3%) | −46.1 | −43.9 | 1.90 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 205 / 6452 (3.2%) | 555 / 64520 (0.9%) | −46.1 | −43.9 | 3.69 |
| ATF3 SRX2207918 | CS1AN Epidermis | 810 / 6452 (12.6%) | 4646 / 64520 (7.2%) | −45.9 | −43.7 | 1.74 |
| FOXA1 SRX100506 | Hep G2 Liver | 227 / 6452 (3.5%) | 5189 / 64520 (8.0%) | −45.8 | −43.6 | 0.44 |
| KMT2A SRX2281249 | SEM Blood | 682 / 6452 (10.6%) | 3685 / 64520 (5.7%) | −45.6 | −43.4 | 1.85 |
| GATA2 SRX16314544 | Trophoblast stem cells Placenta | 104 / 6452 (1.6%) | 3306 / 64520 (5.1%) | −45.6 | −43.4 | 0.31 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 84 / 6452 (1.3%) | 2963 / 64520 (4.6%) | −45.5 | −43.3 | 0.28 |
| ESR1 SRX4451198 | MCF-7 Breast | 253 / 6452 (3.9%) | 816 / 64520 (1.3%) | −45.5 | −43.3 | 3.10 |
| FOXA2 SRX100448 | Hep G2 Liver | 195 / 6452 (3.0%) | 4707 / 64520 (7.3%) | −45.4 | −43.2 | 0.41 |
| CXXC1 SRX1424886 | SEM Blood | 512 / 6452 (7.9%) | 2463 / 64520 (3.8%) | −45.4 | −43.2 | 2.08 |
| ESR1 SRX20282955 | MCF-7 Breast | 183 / 6452 (2.8%) | 4527 / 64520 (7.0%) | −45.3 | −43.1 | 0.40 |
| CHD1 SRX116454 | hESC H1 Pluripotent stem cell | 290 / 6452 (4.5%) | 1030 / 64520 (1.6%) | −45.3 | −43.1 | 2.82 |
| ZFX SRX7805372 | 293 Kidney | 541 / 6452 (8.4%) | 2670 / 64520 (4.1%) | −45.3 | −43.1 | 2.03 |
| ESR1 SRX20282953 | MCF-7 Breast | 145 / 6452 (2.2%) | 3950 / 64520 (6.1%) | −45.3 | −43.1 | 0.37 |
| FOS SRX150478 | MCF 10A Breast | 407 / 6452 (6.3%) | 7613 / 64520 (11.8%) | −45.2 | −43.0 | 0.53 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 174 / 6452 (2.7%) | 4388 / 64520 (6.8%) | −45.1 | −43.0 | 0.40 |
| FOXA1 SRX371480 | MCF-7 Breast | 127 / 6452 (2.0%) | 3659 / 64520 (5.7%) | −45.0 | −42.8 | 0.35 |
| FOXA1 SRX3923514 | MCF-7 Breast | 179 / 6452 (2.8%) | 4456 / 64520 (6.9%) | −45.0 | −42.8 | 0.40 |
| ESR1 SRX20282973 | MCF-7 Breast | 211 / 6452 (3.3%) | 4922 / 64520 (7.6%) | −44.9 | −42.8 | 0.43 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 192 / 6452 (3.0%) | 4644 / 64520 (7.2%) | −44.8 | −42.7 | 0.41 |
| Epitope tags SRX10549777 | K-562 Blood | 863 / 6452 (13.4%) | 5091 / 64520 (7.9%) | −44.8 | −42.6 | 1.70 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 250 / 6452 (3.9%) | 5475 / 64520 (8.5%) | −44.8 | −42.6 | 0.46 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 547 / 6452 (8.5%) | 2731 / 64520 (4.2%) | −44.5 | −42.4 | 2.00 |
| CDK9 SRX7366782 | MCF-7 Breast | 71 / 6452 (1.1%) | 42 / 64520 (0.1%) | −44.5 | −42.4 | 16.90 |
| FOXA1 SRX3931043 | MCF-7 Breast | 183 / 6452 (2.8%) | 4495 / 64520 (7.0%) | −44.4 | −42.3 | 0.41 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 131 / 6452 (2.0%) | 3697 / 64520 (5.7%) | −44.3 | −42.2 | 0.35 |
| FOXA1 SRX3931055 | MCF-7 Breast | 154 / 6452 (2.4%) | 4051 / 64520 (6.3%) | −44.3 | −42.1 | 0.38 |
| ESR1 SRX10365558 | MCF-7 Breast | 118 / 6452 (1.8%) | 3489 / 64520 (5.4%) | −44.3 | −42.1 | 0.34 |
| ESR1 SRX4451196 | MCF-7 Breast | 254 / 6452 (3.9%) | 838 / 64520 (1.3%) | −44.2 | −42.1 | 3.03 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 228 / 6452 (3.5%) | 5137 / 64520 (8.0%) | −44.2 | −42.0 | 0.44 |
| FOXA1 SRX1161174 | MCF-7 Breast | 183 / 6452 (2.8%) | 4479 / 64520 (6.9%) | −44.1 | −41.9 | 0.41 |
| ESR1 SRX2881002 | MCF-7 Breast | 165 / 6452 (2.6%) | 4208 / 64520 (6.5%) | −44.0 | −41.9 | 0.39 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 169 / 6452 (2.6%) | 4269 / 64520 (6.6%) | −43.9 | −41.8 | 0.40 |
| MEAF6 DRX234811 | 293 Kidney | 581 / 6452 (9.0%) | 2991 / 64520 (4.6%) | −43.9 | −41.8 | 1.94 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 165 / 6452 (2.6%) | 4205 / 64520 (6.5%) | −43.9 | −41.8 | 0.39 |
| Epitope tags DRX443510 | 293 Kidney | 499 / 6452 (7.7%) | 2411 / 64520 (3.7%) | −43.8 | −41.7 | 2.07 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 156 / 6452 (2.4%) | 4066 / 64520 (6.3%) | −43.8 | −41.6 | 0.38 |
| RAC1 SRX10365543 | MCF-7 Breast | 100 / 6452 (1.5%) | 3178 / 64520 (4.9%) | −43.8 | −41.6 | 0.31 |
| RUNX1 SRX2014504 | Jurkat Blood | 847 / 6452 (13.1%) | 5006 / 64520 (7.8%) | −43.7 | −41.6 | 1.69 |
| KAT6A SRX20971024 | Fibroblasts Others | 61 / 6452 (0.9%) | 24 / 64520 (0.0%) | −43.7 | −41.5 | 25.42 |
| FOXA2 SRX3230382 | Hep G2 Liver | 235 / 6452 (3.6%) | 5214 / 64520 (8.1%) | −43.6 | −41.5 | 0.45 |
| FOXA1 SRX028635 | MCF-7 Breast | 91 / 6452 (1.4%) | 3013 / 64520 (4.7%) | −43.5 | −41.3 | 0.30 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 292 / 6452 (4.5%) | 5996 / 64520 (9.3%) | −43.3 | −41.2 | 0.49 |
| ESR1 SRX10365532 | MCF-7 Breast | 103 / 6452 (1.6%) | 3208 / 64520 (5.0%) | −43.3 | −41.2 | 0.32 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 257 / 6452 (4.0%) | 5509 / 64520 (8.5%) | −43.3 | −41.2 | 0.47 |
| ESR1 SRX4451213 | MCF-7 Breast | 178 / 6452 (2.8%) | 4372 / 64520 (6.8%) | −43.2 | −41.1 | 0.41 |
| FOXA1 SRX11222437 | MCF-7 Breast | 131 / 6452 (2.0%) | 3648 / 64520 (5.7%) | −43.0 | −40.9 | 0.36 |
| MEAF6 DRX300417 | 293 Kidney | 531 / 6452 (8.2%) | 2657 / 64520 (4.1%) | −42.9 | −40.8 | 2.00 |
| FOXA1 SRX1787652 | MCF-7 Breast | 112 / 6452 (1.7%) | 3341 / 64520 (5.2%) | −42.9 | −40.8 | 0.34 |
| FOXA1 SRX3931054 | MCF-7 Breast | 173 / 6452 (2.7%) | 4283 / 64520 (6.6%) | −42.8 | −40.6 | 0.40 |
| SFPQ SRX593748 | MCF-7 Breast | 1006 / 6452 (15.6%) | 6309 / 64520 (9.8%) | −42.7 | −40.6 | 1.59 |
| FOXA1 SRX1787651 | MCF-7 Breast | 104 / 6452 (1.6%) | 3209 / 64520 (5.0%) | −42.7 | −40.6 | 0.32 |
| PAF1 SRX1873455 | SEM Blood | 244 / 6452 (3.8%) | 804 / 64520 (1.2%) | −42.6 | −40.4 | 3.03 |
| FOXA1 SRX5323843 | MCF-7 Breast | 95 / 6452 (1.5%) | 3052 / 64520 (4.7%) | −42.5 | −40.4 | 0.31 |
| ESR1 SRX20282946 | MCF-7 Breast | 113 / 6452 (1.8%) | 3344 / 64520 (5.2%) | −42.5 | −40.4 | 0.34 |
| ESR1 SRX8537722 | MCF-7 Breast | 168 / 6452 (2.6%) | 4192 / 64520 (6.5%) | −42.4 | −40.3 | 0.40 |
| ESR1 SRX20282940 | MCF-7 Breast | 196 / 6452 (3.0%) | 4604 / 64520 (7.1%) | −42.4 | −40.3 | 0.43 |
| TEAD1 SRX3401272 | MCF-7 Breast | 140 / 6452 (2.2%) | 3763 / 64520 (5.8%) | −42.3 | −40.2 | 0.37 |
| ESR1 SRX20282971 | MCF-7 Breast | 182 / 6452 (2.8%) | 4390 / 64520 (6.8%) | −42.2 | −40.1 | 0.41 |
| BRD2 SRX8090642 | Synoviocytes Others | 392 / 6452 (6.1%) | 1720 / 64520 (2.7%) | −42.1 | −40.0 | 2.28 |
| FOXA1 SRX3923515 | MCF-7 Breast | 103 / 6452 (1.6%) | 3167 / 64520 (4.9%) | −42.1 | −40.0 | 0.33 |
| DNA-RNA hybrid SRX15232261 | MDA-MB-436 Breast | 107 / 6452 (1.7%) | 157 / 64520 (0.2%) | −42.0 | −39.9 | 6.82 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 94 / 6452 (1.5%) | 3015 / 64520 (4.7%) | −42.0 | −39.9 | 0.31 |
| FOS SRX8512767 | HCT 116 Digestive tract | 280 / 6452 (4.3%) | 1021 / 64520 (1.6%) | −41.9 | −39.8 | 2.74 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 156 / 6452 (2.4%) | 3995 / 64520 (6.2%) | −41.9 | −39.8 | 0.39 |
| BRD4 SRX1272808 | COLO 741 Digestive tract | 442 / 6452 (6.9%) | 2060 / 64520 (3.2%) | −41.8 | −39.8 | 2.15 |
| FOXA1 SRX11222441 | MCF-7 Breast | 146 / 6452 (2.3%) | 3839 / 64520 (6.0%) | −41.8 | −39.7 | 0.38 |
| FOXA1 SRX3923518 | MCF-7 Breast | 129 / 6452 (2.0%) | 3567 / 64520 (5.5%) | −41.6 | −39.5 | 0.36 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 152 / 6452 (2.4%) | 3922 / 64520 (6.1%) | −41.6 | −39.5 | 0.39 |
| ESR1 SRX371475 | BT-474 Breast | 97 / 6452 (1.5%) | 3046 / 64520 (4.7%) | −41.4 | −39.3 | 0.32 |
| ESR1 SRX2912055 | MCF-7 Breast | 74 / 6452 (1.1%) | 2650 / 64520 (4.1%) | −41.3 | −39.2 | 0.28 |
| ESR1 SRX330067 | MCF-7 Breast | 163 / 6452 (2.5%) | 4069 / 64520 (6.3%) | −41.1 | −39.0 | 0.40 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 423 / 6452 (6.6%) | 1951 / 64520 (3.0%) | −41.1 | −39.0 | 2.17 |
| KMT2A SRX2281247 | SEM Blood | 561 / 6452 (8.7%) | 2920 / 64520 (4.5%) | −41.1 | −39.0 | 1.92 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 160 / 6452 (2.5%) | 4020 / 64520 (6.2%) | −41.1 | −39.0 | 0.40 |
| FOXA1 SRX3923519 | MCF-7 Breast | 116 / 6452 (1.8%) | 3340 / 64520 (5.2%) | −41.0 | −38.9 | 0.35 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 579 / 6452 (9.0%) | 3056 / 64520 (4.7%) | −41.0 | −38.9 | 1.89 |
| EP300 SRX2671820 | iPS cells Pluripotent stem cell | 45 / 6452 (0.7%) | 2111 / 64520 (3.3%) | −41.0 | −38.9 | 0.21 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 419 / 6452 (6.5%) | 1928 / 64520 (3.0%) | −40.9 | −38.8 | 2.17 |
| MEN1 SRX11712604 | K-562 Blood | 478 / 6452 (7.4%) | 2338 / 64520 (3.6%) | −40.8 | −38.7 | 2.04 |
| RORC SRX5359053 | HCC70 Breast | 424 / 6452 (6.6%) | 1964 / 64520 (3.0%) | −40.7 | −38.6 | 2.16 |
| Epitope tags SRX15725650 | 293 Kidney | 578 / 6452 (9.0%) | 3058 / 64520 (4.7%) | −40.6 | −38.6 | 1.89 |
| ESR1 SRX330070 | MCF-7 Breast | 101 / 6452 (1.6%) | 3087 / 64520 (4.8%) | −40.6 | −38.6 | 0.33 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 453 / 6452 (7.0%) | 2168 / 64520 (3.4%) | −40.6 | −38.5 | 2.09 |
| ING2 SRX286201 | RKO Digestive tract | 484 / 6452 (7.5%) | 2383 / 64520 (3.7%) | −40.5 | −38.4 | 2.03 |
| ESR1 SRX1012632 | MCF-7 Breast | 96 / 6452 (1.5%) | 2996 / 64520 (4.6%) | −40.5 | −38.4 | 0.32 |
| EOMES SRX035159 | hESC derived mesendodermal cells Pluripotent stem cell | 127 / 6452 (2.0%) | 3491 / 64520 (5.4%) | −40.4 | −38.4 | 0.36 |
| FOXA1 SRX100454 | T-47D Breast | 241 / 6452 (3.7%) | 5160 / 64520 (8.0%) | −40.3 | −38.3 | 0.47 |
| CHD1 SRX186771 | K-562 Blood | 245 / 6452 (3.8%) | 842 / 64520 (1.3%) | −40.2 | −38.2 | 2.91 |
| DLX5 SRX7493850 | CAL 27 Others | 163 / 6452 (2.5%) | 407 / 64520 (0.6%) | −40.2 | −38.2 | 4.00 |
| TFAP2C SRX018833 | MCF-7 Breast | 167 / 6452 (2.6%) | 4092 / 64520 (6.3%) | −40.2 | −38.2 | 0.41 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 179 / 6452 (2.8%) | 4267 / 64520 (6.6%) | −40.2 | −38.1 | 0.42 |
| FOXA1 SRX3923511 | MCF-7 Breast | 76 / 6452 (1.2%) | 2647 / 64520 (4.1%) | −40.1 | −38.0 | 0.29 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 73 / 6452 (1.1%) | 2595 / 64520 (4.0%) | −40.1 | −38.0 | 0.28 |
| EP300 SRX1012648 | MCF-7 Breast | 92 / 6452 (1.4%) | 2914 / 64520 (4.5%) | −40.0 | −38.0 | 0.32 |
| CTCF SRX12008350 | MCF 10A Breast | 1041 / 6452 (16.1%) | 6709 / 64520 (10.4%) | −40.0 | −37.9 | 1.55 |
| RAC1 SRX10365541 | MCF-7 Breast | 108 / 6452 (1.7%) | 3172 / 64520 (4.9%) | −39.9 | −37.8 | 0.34 |
| ARID1A SRX5089376 | MCF-7 Breast | 161 / 6452 (2.5%) | 3991 / 64520 (6.2%) | −39.8 | −37.8 | 0.40 |
| FOXA1 SRX1447317 | MCF-7 Breast | 128 / 6452 (2.0%) | 3485 / 64520 (5.4%) | −39.8 | −37.8 | 0.37 |
| FOXA1 SRX11222438 | MCF-7 Breast | 105 / 6452 (1.6%) | 3120 / 64520 (4.8%) | −39.8 | −37.7 | 0.34 |
| FOXA1 SRX1447316 | MCF-7 Breast | 85 / 6452 (1.3%) | 2791 / 64520 (4.3%) | −39.8 | −37.7 | 0.30 |
| RBFOX2 SRX3322781 | K-562 Blood | 695 / 6452 (10.8%) | 3961 / 64520 (6.1%) | −39.8 | −37.7 | 1.75 |
| ESR1 SRX330069 | MCF-7 Breast | 119 / 6452 (1.8%) | 3338 / 64520 (5.2%) | −39.7 | −37.6 | 0.36 |
| FOXA2 SRX11650946 | hESC derived pancreatic cells Pluripotent stem cell | 100 / 6452 (1.5%) | 3033 / 64520 (4.7%) | −39.6 | −37.5 | 0.33 |
| CSTF2 SRX10448647 | HeLa Uterus | 339 / 6452 (5.3%) | 1427 / 64520 (2.2%) | −39.5 | −37.5 | 2.38 |
| FOS SRX4192880 | MCF 10A Breast | 311 / 6452 (4.8%) | 6075 / 64520 (9.4%) | −39.4 | −37.4 | 0.51 |
| EP300 SRX2671806 | iPS cells Pluripotent stem cell | 43 / 6452 (0.7%) | 2022 / 64520 (3.1%) | −39.4 | −37.3 | 0.21 |
| TFAP2C SRX128099 | MCF-7 Breast | 168 / 6452 (2.6%) | 4074 / 64520 (6.3%) | −39.4 | −37.3 | 0.41 |
| FOXA2 SRX11650947 | hESC derived pancreatic cells Pluripotent stem cell | 129 / 6452 (2.0%) | 3482 / 64520 (5.4%) | −39.3 | −37.3 | 0.37 |
| FOXA1 SRX5323845 | MCF-7 Breast | 73 / 6452 (1.1%) | 2568 / 64520 (4.0%) | −39.2 | −37.2 | 0.28 |
| FOXA1 SRX1787654 | MCF-7 Breast | 77 / 6452 (1.2%) | 2636 / 64520 (4.1%) | −39.2 | −37.2 | 0.29 |
| SOX2 SRX5771668 | N2102Ep Gonad | 50 / 6452 (0.8%) | 2151 / 64520 (3.3%) | −39.2 | −37.1 | 0.23 |
| ESR1 SRX3110725 | MCF-7 Breast | 169 / 6452 (2.6%) | 4082 / 64520 (6.3%) | −39.1 | −37.1 | 0.41 |
| ESR1 SRX371474 | BT-474 Breast | 94 / 6452 (1.5%) | 2920 / 64520 (4.5%) | −39.1 | −37.1 | 0.32 |
| Epitope tags SRX15725652 | 293 Kidney | 638 / 6452 (9.9%) | 3549 / 64520 (5.5%) | −39.0 | −37.0 | 1.80 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 162 / 6452 (2.5%) | 3970 / 64520 (6.2%) | −39.0 | −37.0 | 0.41 |
| PGR SRX1012655 | MCF-7 Breast | 126 / 6452 (2.0%) | 3427 / 64520 (5.3%) | −39.0 | −37.0 | 0.37 |
| RBM22 SRX3322379 | Hep G2 Liver | 290 / 6452 (4.5%) | 1129 / 64520 (1.7%) | −39.0 | −37.0 | 2.57 |
| ESR1 SRX4451212 | MCF-7 Breast | 176 / 6452 (2.7%) | 4176 / 64520 (6.5%) | −38.9 | −36.9 | 0.42 |
| EP300 SRX176885 | MCF-7 Breast | 102 / 6452 (1.6%) | 3040 / 64520 (4.7%) | −38.9 | −36.9 | 0.34 |
| NANOG SRX10445309 | Neural crest cells Neural | 104 / 6452 (1.6%) | 3072 / 64520 (4.8%) | −38.8 | −36.8 | 0.34 |
| CTCF SRX12008351 | MCF 10A Breast | 1010 / 6452 (15.7%) | 6502 / 64520 (10.1%) | −38.8 | −36.8 | 1.55 |
| GATA3 SRX5457550 | MCF-7 Breast | 209 / 6452 (3.2%) | 4649 / 64520 (7.2%) | −38.8 | −36.8 | 0.45 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 701 / 6452 (10.9%) | 4036 / 64520 (6.3%) | −38.8 | −36.8 | 1.74 |
| AFF1 SRX2281250 | SEM Blood | 327 / 6452 (5.1%) | 1362 / 64520 (2.1%) | −38.8 | −36.8 | 2.40 |
| ESR1 SRX5323873 | MCF-7 Breast | 222 / 6452 (3.4%) | 4827 / 64520 (7.5%) | −38.8 | −36.8 | 0.46 |
| Epitope tags SRX10715360 | HCB1 Blood | 380 / 6452 (5.9%) | 1710 / 64520 (2.7%) | −38.7 | −36.7 | 2.22 |
| Epitope tags SRX14024876 | Mesenchymal stem cells Others | 764 / 6452 (11.8%) | 4531 / 64520 (7.0%) | −38.7 | −36.7 | 1.69 |
| CHD6 SRX17709200 | C4-2 Prostate | 532 / 6452 (8.2%) | 2776 / 64520 (4.3%) | −38.6 | −36.6 | 1.92 |
| ESR1 SRX1012629 | MCF-7 Breast | 123 / 6452 (1.9%) | 3366 / 64520 (5.2%) | −38.6 | −36.6 | 0.37 |
| ESR1 SRX20282938 | MCF-7 Breast | 156 / 6452 (2.4%) | 3866 / 64520 (6.0%) | −38.5 | −36.5 | 0.40 |
| CHD1 SRX116417 | K-562 Blood | 230 / 6452 (3.6%) | 780 / 64520 (1.2%) | −38.5 | −36.5 | 2.95 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 210 / 6452 (3.3%) | 4649 / 64520 (7.2%) | −38.5 | −36.5 | 0.45 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 62 / 6452 (1.0%) | 2348 / 64520 (3.6%) | −38.5 | −36.5 | 0.26 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 531 / 6452 (8.2%) | 2773 / 64520 (4.3%) | −38.5 | −36.5 | 1.91 |
| ESR1 SRX3123829 | MCF-7 Breast | 114 / 6452 (1.8%) | 3216 / 64520 (5.0%) | −38.4 | −36.4 | 0.35 |
| FOXA1 SRX3931033 | MCF-7 Breast | 129 / 6452 (2.0%) | 3442 / 64520 (5.3%) | −38.3 | −36.3 | 0.37 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 131 / 6452 (2.0%) | 3472 / 64520 (5.4%) | −38.1 | −36.2 | 0.38 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 245 / 6452 (3.8%) | 5118 / 64520 (7.9%) | −38.1 | −36.1 | 0.48 |
| ESR1 SRX5323878 | MCF-7 Breast | 185 / 6452 (2.9%) | 4269 / 64520 (6.6%) | −38.1 | −36.1 | 0.43 |
| ESR1 SRX10365533 | MCF-7 Breast | 95 / 6452 (1.5%) | 2896 / 64520 (4.5%) | −38.0 | −36.1 | 0.33 |
| SOX2 SRX5771666 | N2102Ep Gonad | 43 / 6452 (0.7%) | 1984 / 64520 (3.1%) | −38.0 | −36.0 | 0.22 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 507 / 6452 (7.9%) | 2614 / 64520 (4.1%) | −38.0 | −36.0 | 1.94 |
| KMT2A SRX8151118 | VDH-15 Others | 680 / 6452 (10.5%) | 3904 / 64520 (6.1%) | −38.0 | −36.0 | 1.74 |
| SOX2 SRX512370 | iPS cells Pluripotent stem cell | 39 / 6452 (0.6%) | 1903 / 64520 (2.9%) | −38.0 | −36.0 | 0.20 |
| ESR1 SRX2513521 | MCF-7 Breast | 100 / 6452 (1.5%) | 2975 / 64520 (4.6%) | −38.0 | −36.0 | 0.34 |
| RBM22 SRX4708035 | Hep G2 Liver | 325 / 6452 (5.0%) | 1368 / 64520 (2.1%) | −37.9 | −35.9 | 2.38 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 292 / 6452 (4.5%) | 1157 / 64520 (1.8%) | −37.9 | −35.9 | 2.52 |
| FOXA1 SRX3923516 | MCF-7 Breast | 142 / 6452 (2.2%) | 3628 / 64520 (5.6%) | −37.9 | −35.9 | 0.39 |
| PPP1R10 SRX6435428 | 293 Kidney | 58 / 6452 (0.9%) | 31 / 64520 (0.0%) | −37.8 | −35.8 | 18.71 |
| FOXA1 SRX11222442 | MCF-7 Breast | 137 / 6452 (2.1%) | 3552 / 64520 (5.5%) | −37.8 | −35.8 | 0.39 |
| SREBF2 SRX5359049 | HCC70 Breast | 397 / 6452 (6.2%) | 1845 / 64520 (2.9%) | −37.8 | −35.8 | 2.15 |
| FOXA1 SRX3923512 | MCF-7 Breast | 57 / 6452 (0.9%) | 2238 / 64520 (3.5%) | −37.8 | −35.8 | 0.25 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 467 / 6452 (7.2%) | 2335 / 64520 (3.6%) | −37.7 | −35.8 | 2.00 |
| AGO1 SRX4708086 | K-562 Blood | 217 / 6452 (3.4%) | 718 / 64520 (1.1%) | −37.7 | −35.7 | 3.02 |
| ESR1 SRX8537723 | MCF-7 Breast | 155 / 6452 (2.4%) | 3816 / 64520 (5.9%) | −37.7 | −35.7 | 0.41 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 59 / 6452 (0.9%) | 2270 / 64520 (3.5%) | −37.7 | −35.7 | 0.26 |
| RBFOX2 SRX3323051 | Hep G2 Liver | 517 / 6452 (8.0%) | 2697 / 64520 (4.2%) | −37.6 | −35.7 | 1.92 |
| KMT2A SRX8151120 | VDH-15 Others | 712 / 6452 (11.0%) | 4163 / 64520 (6.5%) | −37.6 | −35.7 | 1.71 |
| ESR1 SRX176856 | MCF-7 Breast | 71 / 6452 (1.1%) | 2479 / 64520 (3.8%) | −37.6 | −35.7 | 0.29 |
| ESR1 SRX1469949 | MCF-7 Breast | 117 / 6452 (1.8%) | 3233 / 64520 (5.0%) | −37.6 | −35.6 | 0.36 |
| SUPT6H SRX15147167 | DLD-1 Digestive tract | 447 / 6452 (6.9%) | 2199 / 64520 (3.4%) | −37.5 | −35.5 | 2.03 |
| FOXA1 SRX100477 | Hep G2 Liver | 218 / 6452 (3.4%) | 4716 / 64520 (7.3%) | −37.5 | −35.5 | 0.46 |
| CDK9 SRX20230567 | Ishikawa Uterus | 595 / 6452 (9.2%) | 3275 / 64520 (5.1%) | −37.4 | −35.5 | 1.82 |
| AR SRX7512713 | VCaP Prostate | 397 / 6452 (6.2%) | 1856 / 64520 (2.9%) | −37.4 | −35.4 | 2.14 |
| ESR1 SRX2513520 | MCF-7 Breast | 125 / 6452 (1.9%) | 3347 / 64520 (5.2%) | −37.4 | −35.4 | 0.37 |
| ESR1 SRX5323877 | MCF-7 Breast | 149 / 6452 (2.3%) | 3712 / 64520 (5.8%) | −37.3 | −35.4 | 0.40 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 532 / 6452 (8.2%) | 2816 / 64520 (4.4%) | −37.3 | −35.3 | 1.89 |
| YAP1 SRX757325 | H2052 Lung | 444 / 6452 (6.9%) | 7698 / 64520 (11.9%) | −37.3 | −35.3 | 0.58 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 74 / 6452 (1.1%) | 2517 / 64520 (3.9%) | −37.2 | −35.3 | 0.29 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 253 / 6452 (3.9%) | 5188 / 64520 (8.0%) | −37.2 | −35.2 | 0.49 |
| EP300 SRX1012644 | MCF-7 Breast | 93 / 6452 (1.4%) | 2832 / 64520 (4.4%) | −37.1 | −35.2 | 0.33 |
| ESR1 SRX2943589 | MCF-7 Breast | 104 / 6452 (1.6%) | 3010 / 64520 (4.7%) | −37.1 | −35.2 | 0.35 |
| MethylCap SRX014767 | NB-4 Blood | 583 / 6452 (9.0%) | 3200 / 64520 (5.0%) | −37.0 | −35.1 | 1.82 |
| MYC SRX19186217 | HeLa Uterus | 297 / 6452 (4.6%) | 1204 / 64520 (1.9%) | −37.0 | −35.1 | 2.47 |
| FOXA1 SRX3923510 | MCF-7 Breast | 78 / 6452 (1.2%) | 2575 / 64520 (4.0%) | −37.0 | −35.0 | 0.30 |
| ESR1 SRX1012633 | MCF-7 Breast | 107 / 6452 (1.7%) | 3047 / 64520 (4.7%) | −36.9 | −34.9 | 0.35 |
| RELA SRX2207673 | HUVEC Cardiovascular | 600 / 6452 (9.3%) | 9600 / 64520 (14.9%) | −36.9 | −34.9 | 0.63 |
| SMAD3 SRX5757566 | SUM 159PT Breast | 405 / 6452 (6.3%) | 1921 / 64520 (3.0%) | −36.8 | −34.9 | 2.11 |
| FOXA1 SRX3931032 | MCF-7 Breast | 121 / 6452 (1.9%) | 3266 / 64520 (5.1%) | −36.8 | −34.9 | 0.37 |
| ARID1A SRX5089379 | MCF-7 Breast | 188 / 6452 (2.9%) | 4262 / 64520 (6.6%) | −36.8 | −34.9 | 0.44 |
| ESR1 SRX330068 | MCF-7 Breast | 101 / 6452 (1.6%) | 2945 / 64520 (4.6%) | −36.6 | −34.7 | 0.34 |
| FOXA1 SRX5203294 | MCF-7 Breast | 62 / 6452 (1.0%) | 2288 / 64520 (3.5%) | −36.6 | −34.7 | 0.27 |
| CDK9 SRX20230573 | Ishikawa Uterus | 732 / 6452 (11.3%) | 4354 / 64520 (6.7%) | −36.6 | −34.7 | 1.68 |
| SAP30 SRX17989897 | MDA-MB-231 Breast | 645 / 6452 (10.0%) | 3684 / 64520 (5.7%) | −36.5 | −34.6 | 1.75 |
| ESR1 SRX1012630 | MCF-7 Breast | 83 / 6452 (1.3%) | 2647 / 64520 (4.1%) | −36.5 | −34.6 | 0.31 |
| ESR1 SRX20282959 | MCF-7 Breast | 91 / 6452 (1.4%) | 2780 / 64520 (4.3%) | −36.5 | −34.6 | 0.33 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 129 / 6452 (2.0%) | 3380 / 64520 (5.2%) | −36.5 | −34.6 | 0.38 |
| EP300 SRX1012643 | MCF-7 Breast | 76 / 6452 (1.2%) | 2526 / 64520 (3.9%) | −36.5 | −34.5 | 0.30 |
| PHF6 SRX11508321 | G-401 Kidney | 518 / 6452 (8.0%) | 2736 / 64520 (4.2%) | −36.5 | −34.5 | 1.89 |
| RELA SRX2207672 | HUVEC Cardiovascular | 637 / 6452 (9.9%) | 10025 / 64520 (15.5%) | −36.5 | −34.5 | 0.64 |
| DNA-RNA hybrid SRX15232266 | MDA-MB-436 Breast | 85 / 6452 (1.3%) | 110 / 64520 (0.2%) | −36.4 | −34.5 | 7.73 |
| KMT2A SRX14127515 | OCI-AML3 Blood | 359 / 6452 (5.6%) | 1620 / 64520 (2.5%) | −36.3 | −34.4 | 2.22 |
| CSTF2 SRX10722980 | U2OS Bone | 253 / 6452 (3.9%) | 945 / 64520 (1.5%) | −36.3 | −34.4 | 2.68 |
| CEBPA SRX2630241 | Hep G2 Liver | 236 / 6452 (3.7%) | 4918 / 64520 (7.6%) | −36.3 | −34.4 | 0.48 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 78 / 6452 (1.2%) | 2553 / 64520 (4.0%) | −36.3 | −34.4 | 0.31 |
| ESR1 SRX792933 | LY2 Breast | 164 / 6452 (2.5%) | 3893 / 64520 (6.0%) | −36.3 | −34.3 | 0.42 |
| BRD2 SRX8090652 | Synoviocytes Others | 396 / 6452 (6.1%) | 1873 / 64520 (2.9%) | −36.2 | −34.3 | 2.11 |
| CHD6 SRX17709201 | C4-2 Prostate | 504 / 6452 (7.8%) | 2640 / 64520 (4.1%) | −36.2 | −34.3 | 1.91 |
| ESR1 SRX2578880 | MDA-MB-231 Breast | 466 / 6452 (7.2%) | 2368 / 64520 (3.7%) | −36.2 | −34.3 | 1.97 |
| SOX13 SRX2636248 | Hep G2 Liver | 261 / 6452 (4.0%) | 5253 / 64520 (8.1%) | −36.2 | −34.2 | 0.50 |
| ZEB1 SRX13298925 | MCF-7 Breast | 129 / 6452 (2.0%) | 3363 / 64520 (5.2%) | −36.1 | −34.2 | 0.38 |
| FOXA1 SRX5323846 | MCF-7 Breast | 79 / 6452 (1.2%) | 2564 / 64520 (4.0%) | −36.1 | −34.2 | 0.31 |
| CHD7 SRX3581504 | iPS cells Pluripotent stem cell | 48 / 6452 (0.7%) | 2019 / 64520 (3.1%) | −36.1 | −34.2 | 0.24 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 193 / 6452 (3.0%) | 4301 / 64520 (6.7%) | −36.0 | −34.1 | 0.45 |
| RBFOX2 SRX3322782 | K-562 Blood | 644 / 6452 (10.0%) | 3693 / 64520 (5.7%) | −36.0 | −34.1 | 1.74 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 193 / 6452 (3.0%) | 4297 / 64520 (6.7%) | −35.9 | −34.0 | 0.45 |
| FOXA1 SRX3931056 | MCF-7 Breast | 124 / 6452 (1.9%) | 3277 / 64520 (5.1%) | −35.8 | −33.9 | 0.38 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 201 / 6452 (3.1%) | 4405 / 64520 (6.8%) | −35.8 | −33.9 | 0.46 |
| FOXA1 SRX5203303 | MCF-7 Breast | 75 / 6452 (1.2%) | 2488 / 64520 (3.9%) | −35.8 | −33.9 | 0.30 |
| FOXA2 SRX11650943 | hESC derived pancreatic cells Pluripotent stem cell | 128 / 6452 (2.0%) | 3334 / 64520 (5.2%) | −35.7 | −33.8 | 0.38 |
| FOS SRX150517 | MCF 10A Breast | 325 / 6452 (5.0%) | 6085 / 64520 (9.4%) | −35.6 | −33.7 | 0.53 |
| KMT2A SRX8151117 | VDH-15 Others | 703 / 6452 (10.9%) | 4164 / 64520 (6.5%) | −35.6 | −33.7 | 1.69 |
| CDK9 SRX20230572 | Ishikawa Uterus | 575 / 6452 (8.9%) | 3184 / 64520 (4.9%) | −35.6 | −33.7 | 1.81 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 184 / 6452 (2.9%) | 4148 / 64520 (6.4%) | −35.4 | −33.5 | 0.44 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 91 / 6452 (1.4%) | 2742 / 64520 (4.2%) | −35.4 | −33.5 | 0.33 |
| SMAD3 SRX5757564 | SUM 159PT Breast | 611 / 6452 (9.5%) | 3463 / 64520 (5.4%) | −35.3 | −33.4 | 1.76 |
| CDK9 SRX20230570 | Ishikawa Uterus | 572 / 6452 (8.9%) | 3172 / 64520 (4.9%) | −35.2 | −33.4 | 1.80 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 248 / 6452 (3.8%) | 5034 / 64520 (7.8%) | −35.2 | −33.3 | 0.49 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 164 / 6452 (2.5%) | 3849 / 64520 (6.0%) | −35.2 | −33.3 | 0.43 |
| ESR1 SRX4451194 | MCF-7 Breast | 180 / 6452 (2.8%) | 547 / 64520 (0.8%) | −35.2 | −33.3 | 3.29 |
| FOXA1 SRX6878603 | LNCAP Prostate | 216 / 6452 (3.3%) | 4590 / 64520 (7.1%) | −35.2 | −33.3 | 0.47 |
| PAF1 SRX17152982 | DLD-1 Digestive tract | 186 / 6452 (2.9%) | 581 / 64520 (0.9%) | −35.0 | −33.2 | 3.20 |
| ESR1 SRX2901942 | Ishikawa Uterus | 390 / 6452 (6.0%) | 1860 / 64520 (2.9%) | −35.0 | −33.2 | 2.10 |
| ESR1 SRX1531796 | MCF-7 Breast | 115 / 6452 (1.8%) | 3106 / 64520 (4.8%) | −35.0 | −33.2 | 0.37 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 184 / 6452 (2.9%) | 4131 / 64520 (6.4%) | −35.0 | −33.1 | 0.45 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 207 / 6452 (3.2%) | 4458 / 64520 (6.9%) | −35.0 | −33.1 | 0.46 |
| GATA3 SRX3292068 | hESC derived trophoblast cells Pluripotent stem cell | 49 / 6452 (0.8%) | 1999 / 64520 (3.1%) | −34.8 | −33.0 | 0.25 |
| KDM5A SRX23740430 | SUM 149PT Breast | 549 / 6452 (8.5%) | 3010 / 64520 (4.7%) | −34.8 | −32.9 | 1.82 |
| ESR1 SRX2513517 | MCF-7 Breast | 142 / 6452 (2.2%) | 3509 / 64520 (5.4%) | −34.8 | −32.9 | 0.40 |
| ESR1 SRX1012628 | MCF-7 Breast | 110 / 6452 (1.7%) | 3020 / 64520 (4.7%) | −34.8 | −32.9 | 0.36 |
| AR SRX10365514 | MCF-7 Breast | 57 / 6452 (0.9%) | 2141 / 64520 (3.3%) | −34.8 | −32.9 | 0.27 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 460 / 6452 (7.1%) | 7764 / 64520 (12.0%) | −34.8 | −32.9 | 0.59 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 140 / 6452 (2.2%) | 3478 / 64520 (5.4%) | −34.8 | −32.9 | 0.40 |
| FOXA1 SRX5203307 | MCF-7 Breast | 67 / 6452 (1.0%) | 2314 / 64520 (3.6%) | −34.7 | −32.8 | 0.29 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 122 / 6452 (1.9%) | 3201 / 64520 (5.0%) | −34.7 | −32.8 | 0.38 |
| AFF4 SRX573032 | HeLa Uterus | 101 / 6452 (1.6%) | 178 / 64520 (0.3%) | −34.7 | −32.8 | 5.67 |
| ESR1 SRX4451214 | MCF-7 Breast | 176 / 6452 (2.7%) | 4002 / 64520 (6.2%) | −34.6 | −32.8 | 0.44 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 192 / 6452 (3.0%) | 4227 / 64520 (6.6%) | −34.5 | −32.6 | 0.45 |
| ESR1 SRX1012631 | MCF-7 Breast | 98 / 6452 (1.5%) | 2820 / 64520 (4.4%) | −34.4 | −32.6 | 0.35 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 142 / 6452 (2.2%) | 3495 / 64520 (5.4%) | −34.4 | −32.5 | 0.41 |
| ESR1 SRX3110723 | MCF-7 Breast | 117 / 6452 (1.8%) | 3117 / 64520 (4.8%) | −34.4 | −32.5 | 0.38 |
| KMT2A SRX8151119 | VDH-15 Others | 642 / 6452 (10.0%) | 3732 / 64520 (5.8%) | −34.4 | −32.5 | 1.72 |
| ESR1 SRX5323872 | MCF-7 Breast | 194 / 6452 (3.0%) | 4246 / 64520 (6.6%) | −34.3 | −32.5 | 0.46 |
| NANOG SRX2881137 | hESC H9 Pluripotent stem cell | 66 / 6452 (1.0%) | 2284 / 64520 (3.5%) | −34.3 | −32.5 | 0.29 |
| CBFB SRX265218 | ME-1 Blood | 489 / 6452 (7.6%) | 2583 / 64520 (4.0%) | −34.3 | −32.5 | 1.89 |
| GATAD2A SRX2636506 | Hep G2 Liver | 253 / 6452 (3.9%) | 5064 / 64520 (7.8%) | −34.3 | −32.5 | 0.50 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 193 / 6452 (3.0%) | 4231 / 64520 (6.6%) | −34.3 | −32.5 | 0.46 |
| INTS3 SRX3640569 | HeLa Uterus | 419 / 6452 (6.5%) | 2080 / 64520 (3.2%) | −34.3 | −32.4 | 2.01 |
| CEBPB SRX190345 | MCF-7 Breast | 161 / 6452 (2.5%) | 3769 / 64520 (5.8%) | −34.3 | −32.4 | 0.43 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 513 / 6452 (8.0%) | 8396 / 64520 (13.0%) | −34.3 | −32.4 | 0.61 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 195 / 6452 (3.0%) | 4255 / 64520 (6.6%) | −34.3 | −32.4 | 0.46 |
| RBM22 SRX10977334 | K-562 Blood | 191 / 6452 (3.0%) | 619 / 64520 (1.0%) | −34.2 | −32.4 | 3.09 |
| VGLL1 SRX24602134 | BeWo Placenta | 151 / 6452 (2.3%) | 3618 / 64520 (5.6%) | −34.2 | −32.4 | 0.42 |
| GATA3 SRX6712581 | MCF-7 Breast | 171 / 6452 (2.7%) | 3912 / 64520 (6.1%) | −34.2 | −32.3 | 0.44 |
| YAP1 SRX757326 | H2052 Lung | 395 / 6452 (6.1%) | 6914 / 64520 (10.7%) | −34.2 | −32.3 | 0.57 |
| ARID5B SRX10475139 | Hep G2 Liver | 219 / 6452 (3.4%) | 4587 / 64520 (7.1%) | −34.2 | −32.3 | 0.48 |
| JADE3 DRX300415 | 293 Kidney | 490 / 6452 (7.6%) | 2597 / 64520 (4.0%) | −34.1 | −32.3 | 1.89 |
| STAT5A SRX9681372 | ARP-1 Blood | 459 / 6452 (7.1%) | 2372 / 64520 (3.7%) | −34.1 | −32.3 | 1.94 |
| SOX5 SRX2636544 | Hep G2 Liver | 206 / 6452 (3.2%) | 4400 / 64520 (6.8%) | −34.0 | −32.2 | 0.47 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 170 / 6452 (2.6%) | 3890 / 64520 (6.0%) | −34.0 | −32.2 | 0.44 |
| ESR1 SRX1012625 | MCF-7 Breast | 114 / 6452 (1.8%) | 3052 / 64520 (4.7%) | −34.0 | −32.2 | 0.37 |
| GATA3 SRX176866 | MCF-7 Breast | 68 / 6452 (1.1%) | 2306 / 64520 (3.6%) | −34.0 | −32.1 | 0.29 |
| HMG20A SRX2630163 | Hep G2 Liver | 126 / 6452 (2.0%) | 3235 / 64520 (5.0%) | −34.0 | −32.1 | 0.39 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 78 / 6452 (1.2%) | 2473 / 64520 (3.8%) | −34.0 | −32.1 | 0.32 |
| MYBL2 SRX4213900 | MCF 10A Breast | 79 / 6452 (1.2%) | 102 / 64520 (0.2%) | −34.0 | −32.1 | 7.75 |
| NANOG SRX702041 | hESC HUES64 Pluripotent stem cell | 32 / 6452 (0.5%) | 1644 / 64520 (2.5%) | −33.9 | −32.1 | 0.19 |
| FOXA2 SRX11650941 | hESC derived pancreatic cells Pluripotent stem cell | 111 / 6452 (1.7%) | 3003 / 64520 (4.7%) | −33.9 | −32.0 | 0.37 |
| ESR1 SRX5534831 | MCF-7 Breast | 162 / 6452 (2.5%) | 3765 / 64520 (5.8%) | −33.8 | −32.0 | 0.43 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 142 / 6452 (2.2%) | 3471 / 64520 (5.4%) | −33.8 | −32.0 | 0.41 |
| ZFX SRX7805370 | 293 Kidney | 372 / 6452 (5.8%) | 1767 / 64520 (2.7%) | −33.8 | −31.9 | 2.11 |
| AR SRX1067071 | LHSAR Prostate | 362 / 6452 (5.6%) | 6475 / 64520 (10.0%) | −33.8 | −31.9 | 0.56 |
| ESR1 SRX1469951 | MCF-7 Breast | 116 / 6452 (1.8%) | 3074 / 64520 (4.8%) | −33.8 | −31.9 | 0.38 |
| EP300 SRX176883 | MCF-7 Breast | 103 / 6452 (1.6%) | 2875 / 64520 (4.5%) | −33.8 | −31.9 | 0.36 |
| ESR1 SRX4451195 | MCF-7 Breast | 205 / 6452 (3.2%) | 702 / 64520 (1.1%) | −33.7 | −31.9 | 2.92 |
| FOXA1 SRX3923508 | MCF-7 Breast | 72 / 6452 (1.1%) | 2366 / 64520 (3.7%) | −33.7 | −31.9 | 0.30 |
| ESR1 SRX5323871 | MCF-7 Breast | 214 / 6452 (3.3%) | 4495 / 64520 (7.0%) | −33.6 | −31.8 | 0.48 |
| STAT1 SRX23678708 | K-562 Blood | 495 / 6452 (7.7%) | 2646 / 64520 (4.1%) | −33.6 | −31.8 | 1.87 |
| KDM5A SRX23740431 | SUM 149PT Breast | 481 / 6452 (7.5%) | 2543 / 64520 (3.9%) | −33.6 | −31.8 | 1.89 |
| KMT2B DRX059614 | HB1119 Blood | 282 / 6452 (4.4%) | 1173 / 64520 (1.8%) | −33.6 | −31.7 | 2.40 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 194 / 6452 (3.0%) | 4213 / 64520 (6.5%) | −33.5 | −31.7 | 0.46 |
| FOXA1 SRX6878604 | LNCAP Prostate | 168 / 6452 (2.6%) | 3839 / 64520 (6.0%) | −33.5 | −31.7 | 0.44 |
| FOXA1 SRX3923513 | MCF-7 Breast | 72 / 6452 (1.1%) | 2357 / 64520 (3.7%) | −33.4 | −31.6 | 0.31 |
| MLLT1 SRX10131668 | Bronchial tracheal epithelial cells Lung | 58 / 6452 (0.9%) | 43 / 64520 (0.1%) | −33.4 | −31.6 | 13.49 |
| ESR1 SRX2513519 | MCF-7 Breast | 117 / 6452 (1.8%) | 3077 / 64520 (4.8%) | −33.4 | −31.6 | 0.38 |
| ESR1 SRX5287697 | MCF-7 Breast | 87 / 6452 (1.3%) | 2604 / 64520 (4.0%) | −33.4 | −31.5 | 0.33 |
| SUPT6H SRX5771378 | HCT 116 Digestive tract | 109 / 6452 (1.7%) | 220 / 64520 (0.3%) | −33.3 | −31.5 | 4.95 |
| FOXA2 SRX886445 | Caco-2 Digestive tract | 77 / 6452 (1.2%) | 2434 / 64520 (3.8%) | −33.3 | −31.5 | 0.32 |
| PSIP1 SRX1293534 | MV-4-11 Blood | 286 / 6452 (4.4%) | 1203 / 64520 (1.9%) | −33.3 | −31.5 | 2.38 |
| KMT2B DRX059615 | HB1119 Blood | 278 / 6452 (4.3%) | 1155 / 64520 (1.8%) | −33.3 | −31.4 | 2.41 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 228 / 6452 (3.5%) | 4675 / 64520 (7.2%) | −33.3 | −31.4 | 0.49 |
| FOXA2 SRX11650942 | hESC derived pancreatic cells Pluripotent stem cell | 110 / 6452 (1.7%) | 2964 / 64520 (4.6%) | −33.2 | −31.4 | 0.37 |
| BRD7 SRX18945348 | 786-O Kidney | 267 / 6452 (4.1%) | 1084 / 64520 (1.7%) | −33.2 | −31.4 | 2.46 |
| FOXA1 SRX10024494 | MCF-7 Breast | 43 / 6452 (0.7%) | 1835 / 64520 (2.8%) | −33.1 | −31.3 | 0.23 |
| SAP30 SRX17989898 | MDA-MB-231 Breast | 506 / 6452 (7.8%) | 2746 / 64520 (4.3%) | −33.0 | −31.2 | 1.84 |
| Epitope tags SRX5577144 | LNCAP Prostate | 187 / 6452 (2.9%) | 4089 / 64520 (6.3%) | −33.0 | −31.2 | 0.46 |
Showing first 500 of 12491 rows.